NIH-funded research NIH-funded research

Understanding and treating aggressive prostate cancer

Official title: UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer

Funded at University of California, San Francisco · NIH-10769613 · Data updated 2026-11-12

This study is looking into prostate cancer to find out what makes it aggressive and to develop better treatments, so men facing this disease can have more effective options and improved outcomes.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 2, 2024
Project endAugust 31, 2029
Funding year2024
Award (this year)$2,204,158
NIH project number1P50CA275741-01A1
Project IDNIH-10769613 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include men diagnosed with advanced or aggressive prostate cancer, particularly those with metastatic castration-resistant prostate cancer.

Less likely to help

Patients with early-stage prostate cancer or those without a diagnosis of prostate cancer may not benefit from this research.

What this research studies

This research focuses on prostate cancer, which is a leading cause of cancer deaths among men in the U.S. The UCSF Prostate Cancer SPORE aims to reduce the impact of this disease by exploring its biological mechanisms and developing new treatment strategies. The team will investigate the molecular drivers of aggressive prostate cancer, create biomarkers to guide treatment, and address therapeutic resistance in advanced cases. Through collaborative and transdisciplinary approaches, the research seeks to translate scientific findings into effective clinical applications.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with aggressive prostate cancer.

How similar studies have gone: Previous research has shown promise in similar approaches to understanding and treating prostate cancer, indicating potential for success in this area.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Small, Eric J — University of California, San Francisco
  • Study coordinator: Small, Eric J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.